KISS Study: Kinase Inhibition With Sprycel Start up

NCT03193281 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloid Leukemia

Interventions

DRUG: Dasatinib
DRUG: Imatinib

Sponsor

University of Auckland, New Zealand

Collaborators

[object Object]